Monopar Therapeutics is developing cancer therapeutics, including Validive, a tablet for treatment of oral mucositis, Camsirubicin, a soft tissue sarcoma treatment, and MNPR-101 and MNPR-202 for treating various cancers. It also has collaborations with other organizations for further research into cancer treatment. Monopar Therapeutics was founded in 2014 and is located in Wilmette, Illinois.